The cost of providing post-operative “active care” to patients with Crohn’s disease may be high, but new Australian led research suggests it could help prevent recurrence of the disease and reduce costs overall. In a prospective study published in the World Journal of Gastroenterology, researchers found drug therapy was the major cost component of post-intestinal ...
High post-op costs pay off in Crohns: POCER
By Amanda Sheppeard
13 May 2016